Form 8-K - Current report:
SEC Accession No. 0000886163-19-000027
Filing Date
2019-02-07
Accepted
2019-02-07 16:16:29
Documents
3
Period of Report
2019-02-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 lgnd-form8xkq4xnextgen.htm 8-K 25214
2 q42018earningsrelease1.htm EX-99.1 274953
3 image1.jpg GRAPHIC 36525
  Complete submission text file 0000886163-19-000027.txt   351683
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 19575370
SIC: 2834 Pharmaceutical Preparations